AngioDynamics
ANGO
167 hedge funds and large institutions have $497M invested in AngioDynamics in 2025 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 55 increasing their positions, 53 reducing their positions, and 11 closing their positions.
227% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 11
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
16% more funds holding
Funds holding: 144 → 167 (+23)
14% more capital invested
Capital invested by funds: $436M → $497M (+$61.1M)
4% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 53
1.98% less ownership
Funds ownership: 96.28% → 94.3% (-2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$4.76M |
| 2 |
Nuveen
Charlotte,
North Carolina
|
+$4.61M |
| 3 |
State Street
Boston,
Massachusetts
|
+$3.9M |
| 4 |
RA
Royce & Associates
New York
|
+$3.36M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$3.29M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DSCM
Divisadero Street Capital Management
Miami,
Florida
|
-$41.1M |
| 2 |
Millennium Management
New York
|
-$11.7M |
| 3 |
AI
Acuitas Investments
Seattle,
Washington
|
-$5.57M |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$4.6M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$2.95M |
ANGO Hedge Fund Activity: Q4 2025 in Review
167 of the 8,267 institutional investors tracked by Wall St. Rank reported a position in AngioDynamics (ANGO) for Q4 2025, worth a combined $497M — up 14% from $436M a quarter earlier.
Buyers outnumbered sellers: 36 funds opened new ANGO positions and 11 closed out — a net gain of 25 holders — while 55 added to existing stakes and 53 trimmed.
The largest buyer was BlackRock, adding an estimated $4.76M. The largest seller was Divisadero Street Capital Management, exiting entirely with an estimated $41.1M sold.
- 167 institutional investors held AngioDynamics (ANGO) as of Q4 2025, up from 144 in Q3 2025.
- Funds reported $497M of AngioDynamics stock for Q4 2025, up 14% quarter-over-quarter.
- 36 funds opened new AngioDynamics positions in Q4 2025 and 11 closed out, a net change of +25 holders.
- The largest AngioDynamics buyer in Q4 2025 was BlackRock, an estimated $4.76M added.
- The largest AngioDynamics seller in Q4 2025 was Divisadero Street Capital Management, an estimated $41.1M sold.
Based on aggregated 13F filings for Q4 2025.